DFTX — Definium Therapeutics Share News
0.000.00%
Brief: Mindmed Announces First Patient Dosed In Phase 3 Voyage Study Of Mm120 In Generalized Anxiety Disorder (Gad)
U.S. RESEARCH ROUNDUP-Bath & Body Works, Datadog, Savers value Village
Mind Medicine (MindMed) Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: MindMed Q3 Net Income USD -13.684 Million
Mind Medicine (MindMed) Inc reports results for the quarter ended in June - Earnings Summary
Brief: MindMed Q2 Net Income USD -5.854 Million
Mind Medicine (MindMed) Inc expected to post a loss of 33 cents a share - Earnings Preview
Brief: Mind Medicine (Mindmed) Inc. Announces Proposed Public Offering
Mind Medicine (MindMed) Inc expected to post a loss of 33 cents a share - Earnings Preview
Brief: Mindmed Announces Issuance Of New Patent For MM120 Orally Disintegrating Tablet
Brief: Mind Medicine Files For Mixed Shelf-SEC Filing
U.S. RESEARCH ROUNDUP-Autodesk, McKesson, Microstrategy
Brief: MindMed Q1 Net Income USD -54.4 Million
Mind Medicine (MindMed) Inc expected to post a loss of 53 cents a share - Earnings Preview
Mind Medicine (MindMed) Inc expected to post a loss of 53 cents a share - Earnings Preview
Brief: Mindmed Announces Voluntary Delisting From Cboe Canada
Brief: Mind Medicine Offering 16.7 Million Common Shares, At $6.00 Per Share
U.S. STOCKS ON THE MOVE-Teladoc Health, Hamilton Insurance, SciSparc
U.S. STOCKS ON THE MOVE-SciSparc, gold miners, Teladoc